• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.39% Nasdaq Up1.52%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    4.81 Up 0.01(0.21%) 10:30AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 9,415   7,788   7,979   24,349  
    Cost of Revenue -   -   -   -  
    Gross Profit 9,415   7,788   7,979   24,349  
    Operating Expenses
    Research Development11,420  11,737  12,490  13,824  
    Selling General and Administrative3,993  4,458  4,259  4,093  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (5,998) (8,407) (8,770) 6,432  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes(5,971)(8,374)(8,744)6,531  
    Interest Expense -   -   -   -  
    Income Before Tax(5,971)(8,374)(8,744)6,531  
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(5,971)(8,374)(8,744)6,531  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (5,971) (8,374) (8,744) 6,531  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (5,971) (8,374) (8,744) 6,531  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.